Methyl 4-(tert-Butoxycarbonylamino)bicyclo[2.1.1]hexane-1-carboxylate, 98%, 1g

Ethyl 3-hydroxy-5-methylbenzoate, 97%, 1g

Methyl 2-Chloro-4-nitrobenzoate>99.0%(GC)5g

5-Chloro-2-hydroxy-4-methyl-benzaldehyde, 95.0%, 1g

(S)-(-)Bromosuccinic acid, 95.0%, 25g

Methyl 4,5-dibromo-3-fluorothiophene-2-carboxylate, 95+%, 250mg

(S)-1-(4-Chlorophenyl)ethanamine hydrochloride, 95.0%, 25g

(R)-2-Cyclopropyl-piperazine dihydrochloride, 98%, 500mg

GC capillary column ROTI®Cap-5, 30 m, 0.25 mm, 0.50 µm, 1 Piece(s)

N-(5-Nitrothiazol-2-yl)acetamide, 95.0%, 50g

4-(4-Bromophenyl)-5-methyl-1H-pyrazol-3-amine, 98%, 5g

5-Methyl-2-(4-methoxyphenyl)pyridine, 97%, 250mg

TERT-BUTYL 7-(HYDROXYMETHYL)-5-OXA-2-AZASPIRO[3.4]OCTANE-2-CARBOXYLATE, 95.0%, 1g